Injury to the bladders internal surface is a common factor in IC/BPS
discuss dose adjustment with your prescriber if constipation significantly impacts quality of life
As of April 2026, the FDA removed BPC-157 from Category 2 following withdrawal of nominations, and has announced a Pharmacy Compounding Advisory Committee (PCAC) meeting for July 2026 to assess BPC-157 acetate and free base for the 503A bulks list indicating the regulatory question remains unresolved
Janubov M, itanov I (2024) The effects of vitamin D on different types of cells
Refrigerate opened vials at 28C, mark the 28-day discard date, and treat temperature excursions as protocol failures
Shahreyar M, Fahhoum R, Akinseye O, Bhandari S, Dang G, Khouzam RN